Granules India Ltd-$ - 532482 - Board Meeting Intimation for Inter-Alia, To Consider And Approve The Audited Financial Results For The Fourth Quarter And Financial Year Ended On March 31, 2026 And The Recommendation Of Final Dividend For FY 2025-26, If Any.
Granules India's board is scheduled to meet on April 29, 2026. The agenda includes considering and approving the audited financial results for the fourth quarter and full fiscal year 2026, along with a recommendation for a final dividend.
Apr 16 2026 11:04:00
Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited's Chantilly, US site completed a US FDA cGMP audit with four Form 483 observations. These observations are related to procedural matters, with no data integrity issues reported. The company is committed to addressing them within stipulated timelines.
Apr 04 2026 15:04:00
Granules India Limited
Granules India's US subsidiary, Granules Pharmaceuticals, completed a routine US FDA cGMP audit at its Chantilly, Virginia site. The audit found four procedural Form 483 observations but no data integrity issues. The company commits to address these within stipulated timelines.
Apr 04 2026 15:04:00
Granules India Limited
Granules India's promoter, Dr. Krishna Prasad Chigurupati, declared that no new encumbrance has been made on the company's shares during the financial year ended March 31, 2026, other than those already disclosed. This ensures transparency regarding promoter shareholdings.
Apr 02 2026 18:04:00
Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Life Sciences, a subsidiary of Granules India, received a Voluntary Action Indicated (VAI) classification from the US FDA for its Shamirpet manufacturing facility. The inspection, conducted between December 15 and 19, 2025, for cGMP and PAI of oral solid dosage operations, concluded with no regulatory action recommended, bolstering its finished dosage manufacturing capabilities.
Mar 31 2026 11:03:00
Read More